The positive effect of immune checkpoint inhibitor-induced thyroiditis on overall survival accounting for immortal time bias: a retrospective cohort study of 6596 patients.

Street, S; Chute, D; Strohbehn, I; Zhao, S; Rengarajan, M; Faje, A; Seethapathy, H; Lee, M; Seethapathy, R; Drobni, Z; Rahma, O; Neilan, T G; Sullivan, R J; Villani, A C; Zubiri, L; Mooradian, M J; Reynolds, K L; Sise, M E

Street, S; Chute, D; Strohbehn, I; Zhao, S; Rengarajan, M; Faje, A; Seethapathy, H; Lee, M; Seethapathy, R; Drobni, Z; Rahma, O; Neilan, T G; Sullivan, R J; Villani, A C; Zubiri, L; Mooradian, M J; Reynolds, K L; Sise, M E.

Afiliação

Street S; Department of Medicine, Massachusetts General Hospital, Boston, USA.
Chute D; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Strohbehn I; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Zhao S; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Rengarajan M; Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Faje A; Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Seethapathy H; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Lee M; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Seethapathy R; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, USA.
Drobni Z; Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Boston, USA; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
Rahma O; Division of Hematology and Oncology, Dana Farber Cancer Institute, Boston, USA.
Neilan TG; Cardio-Oncology Program, Division of Cardiology Department of Medicine, Massachusetts General Hospital, Boston, USA.
Sullivan RJ; Cardio-Oncology Program, Division of Cardiology Department of Medicine, Massachusetts General Hospital, Boston, USA.
Villani AC; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, USA.
Zubiri L; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, USA.
Mooradian MJ; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, USA.
Reynolds KL; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, USA.
Sise ME; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, USA. Electronic address: msise@partners.org.

Ann Oncol ; 32(8): 1050-1051, 2021 08.

Article em En | MEDLINE | ID: mdl-34020034

Assuntos

Inibidores de Checkpoint Imunológico; Tireoidite; Viés; Humanos; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tireoidite / Inibidores de Checkpoint Imunológico Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google